zimeta- dipyrone injection
dechra vet products, llc - dipyrone (unii: 6429l0l52y) (metamizole - unii:934t64rmnj) - indication: zimeta® (dipyrone injection) is indicated for the control of pyrexia in horses. contraindications: horses with hypersensitivity to dipyrone should not receive zimeta. due to the prolongation of prothrombin time (pt) and associated clinical signs of coagulopathy, dipyrone should not be given more frequently than every 12 hours.
cleamine combination tablets a1.0 (クリアミン配合錠a1.0)
nichi-iko pharmaceutical co.,ltd - ergotamine tartrate; anhydrous caffeine; isopropylantipyrine - light yellow tablet, diameter: 11.5 mm, thickness: 5.6 mm
cleamine combination tablets s0.5 (クリアミン配合錠s0.5)
nichi-iko pharmaceutical co.,ltd - ergotamine tartrate; anhydrous caffeine; isopropylantipyrine - light orange tablet, diameter: 9.0 mm, thickness: 5.0 mm
artrol liquid
les produits gerbex inc. - cimicifuga racemosa; taraxacum officinale weber; antipyrine; sodium salicylate; sodium bicarbonate; methyl salicylate - liquid - 266mg; 355mg; 142mg; 811mg; 73mg; .0114ml - cimicifuga racemosa 266mg; taraxacum officinale weber 355mg; antipyrine 142mg; sodium salicylate 811mg; sodium bicarbonate 73mg; methyl salicylate .0114ml - salicylates
antidouleurs rezall liquid
produits francais labs inc. - sodium salicylate; antipyrine - liquid - 600mg; 180mg - sodium salicylate 600mg; antipyrine 180mg - opiate partial agonists
eye brite liq liquid
lambert kay, division of carter wallace inc. - boric acid; antipyrine; benzalkonium chloride; zinc sulfate - liquid - 2%; .4%; .01%; .1% - boric acid 2%; antipyrine .4%; benzalkonium chloride .01%; zinc sulfate .1% - cats; dogs
formule l2 liquid
herbages naturbec ltÉe. - sodium salicylate; antipyrine - liquid - 56mg; 10mg - sodium salicylate 56mg; antipyrine 10mg - salicylates
oti cal drops
produits francais labs inc. - benzocaine; antipyrine - drops - 15.3mg; 58mg - benzocaine 15.3mg; antipyrine 58mg - local anesthetics
auralgan solution
paladin labs inc. - benzocaine; antipyrine - solution - 14mg; 54mg - benzocaine 14mg; antipyrine 54mg - local anesthetics
cesamet- nabilone capsule
meda pharmaceuticals - nabilone (unii: 2n4o9l084n) (nabilone - unii:2n4o9l084n) - nabilone 1 mg - cesamet capsules are indicated for the treatment of the nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. this restriction is required because a substantial proportion of any group of patients treated with cesamet can be expected to experience disturbing psychotomimetic reactions not observed with other antiemetic agents. because of its potential to alter the mental state, cesamet is intended for use under circumstances that permit close supervision of the patient by a responsible individual particularly during initial use of cesamet and during dose adjustments. cesamet contains nabilone, which is controlled in schedule ii of the controlled substances act. schedule ii substances have a high potential for abuse. prescriptions for cesamet should be limited to the amount necessary for a single cycle of chemotherapy (i.e., a few days). cesamet capsules are not intended to be used on as needed basis or as a first antieme